09:10:05 EDT Mon 24 Jun 2024
Enter Symbol
or Name

Login ID:

Q:TDSGF - TELO GENOMICS CORP - http://www.3dsignatures.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TDSGF - Qnot subscribed0.1437    0.2372  0.0761Jun 21Jun 1815 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-06-18 08:46U:TDSGFNews ReleaseTelo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP
2024-06-12 08:46U:TDSGFNews ReleaseTelo Genomics Presents Proprietary Artificial Intelligence Methodologies at ASCO 2024
2024-05-30 08:46U:TDSGFNews ReleaseTelo Genomics Announces Publication of Results from Its Smoldering Myeloma Clinical Study in the American Journal of Hematology
2024-05-15 08:46U:TDSGFNews ReleaseTelo Genomics and Emery Pharma Announce Collaboration
2024-04-10 08:46U:TDSGFNews ReleaseTelo Genomics Receives Accreditation from College of American Pathologists
2024-04-02 08:46U:TDSGFNews ReleaseTelo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial
2024-02-13 08:46U:TDSGFNews ReleaseTelo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients
2024-01-30 09:15U:TDSGFNews ReleaseMultiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
2024-01-30 08:46U:TDSGFNews ReleaseTelo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US
2023-12-06 08:46U:TDSGFNews ReleaseTelo Genomics Gears up for American Society of Hematology Conference
2023-11-16 09:16U:TDSGFNews ReleaseTelo Genomics Launches Physician Experience Program in the United States
2023-11-07 08:46U:TDSGFNews ReleaseTelo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists
2023-11-01 08:46U:TDSGFNews ReleaseAmerican Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting
2023-10-26 08:46U:TDSGFNews ReleaseTelo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation
2023-10-17 08:46U:TDSGFNews ReleaseTelo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM - An Important Commercial Milestone Achieved
2023-10-12 09:48U:TDSGFNews ReleaseTelo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting
2023-09-06 09:01U:TDSGFNews ReleaseTelo Genomics Achieves Noteworthy International Standards Organization ("ISO") Regulatory Accreditation
2023-08-29 16:36U:TDSGFNews ReleaseTelo Genomics Reports Substantial Progress Toward Clinical Launch of TeloView-SMM
2023-06-30 08:46U:TDSGFNews ReleaseTelo Genomics Announces Agreement for Strategic Advisory Services